Press "Enter" to skip to content

Genomic Profiling Confirms MAPK/ERK Gene Alterations in Metastatic Prostate Cancer – OncLive

admin 0

Genomic Profiling Confirms MAPK/ERK Gene Alterations in Metastatic Prostate Cancer  OncLive

MAPK/ERK gene alterations, primarily receptor tyrosine kinases, BRAF, and CDK4/6 amplifications, were found to be present in more than half of patients with …

“prostate cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *